We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

36 hedge funds and large institutions have $42M invested in Global Cord Blood Corporation in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more capital invested

Capital invested by funds: $31.6M → $42M (+$10.4M)

1.69% more ownership

Funds ownership: 7.02%8.71% (+1.7%)

9% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 11

3% less funds holding

Funds holding: 3736 (-1)

36% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 14

Holders
36
Holders Change
-1
Holders Change %
-2.7%
% of All Funds
1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
9
Reduced
14
Closed
11
Calls
Puts
Net Calls
Net Calls Change

CO Hedge Fund Activity: Q3 2015 in Review

36 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q3 2015, worth a combined $42M — up 33% from $31.6M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of CO and 10 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 9 added.

The largest buyer was Citigroup, adding an estimated $8.16M. The largest seller was Arrowstreet Capital, exiting entirely with an estimated $1.14M sold.

  • 36 institutional investors held Global Cord Blood Corporation (CO) as of Q3 2015, down from 37 in Q2 2015.
  • Funds reported $42M of Global Cord Blood Corporation stock for Q3 2015, up 33% quarter-over-quarter.
  • 10 funds opened new Global Cord Blood Corporation positions in Q3 2015 and 11 closed out, a net change of -1 holder.
  • The largest Global Cord Blood Corporation buyer in Q3 2015 was Citigroup, an estimated $8.16M added.
  • The largest Global Cord Blood Corporation seller in Q3 2015 was Arrowstreet Capital, an estimated $1.14M sold.

Based on aggregated 13F filings for Q3 2015.